Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WD40 repeat-containing protein SMU1 is a multifunctional scaffold protein located in the nucleus, participating in both DNA replication regulation and pre-mRNA splicing as part of the spliceosome[1][2][5][6][7]. SMU1 forms complexes (notably with RED) that facilitate the activation of spliceosomes, especially crucial on short introns where structural constraints exist between splice sites[5]. Loss of SMU1 function accelerates DNA synthesis, activates replication checkpoints, and increases genomic instability, highlighting its role in maintaining genomic integrity[2][1]. SMU1 also operates as a substrate recognition module for the CRL7SMU1 E3 ubiquitin ligase complex, contributing to histone H2B monoubiquitylation and proper sister chromatid cohesion[1][5]. Although WD40 proteins are increasingly recognized as druggable, there are no established drugs or clinical inhibitors specifically targeting SMU1 to date[8].
None currently known for drugs (potential for future ligand-based modulation per WD40 druggability studies[8])
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WD40 repeat-containing protein SMU1 (SMU1).